# Evaluation of CEMIP in Pancreatic Cancer

> **NCT03679910** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 90 (estimated)

## Conditions studied

- Pancreas Cancer

## Interventions

- **DIAGNOSTIC_TEST:** CEMIP , CA19-9 ,CEA
- **DIAGNOSTIC_TEST:** A) CBC . B) RBG. C)KFT. D) LFT.

## Key facts

- **NCT ID:** NCT03679910
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679910, "Evaluation of CEMIP in Pancreatic Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03679910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*